Evidence map›Paper›PMID 23450732›Full record

ArticleFrontiers in plant science2013

Fusarium graminearum and Its Interactions with Cereal Heads: Studies in the Proteomics Era.

Fen Yang, Susanne Jacobsen, Hans J L Jørgensen, David B Collinge, Birte Svensson, Christine Finnie

Abstract read
In one paragraph

Article in Frontiers in plant science, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. On the Antimicrobial Potential ofInternational journal of molecular sciences · 2025
    Article
  4. In Vitro Evaluation of the Antifungal Activity ofPlants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. 3-keto-DON, but Not 3-International journal of molecular sciences · 2022
    Article
  12. Article
  13. Biocontrol ofToxins · 2022
    Article
  14. Review
  15. Genetic Diversity ofMycobiology · 2022
    Article
  16. Article
  17. Article
  18. Review
  19. Transcriptional Responses ofJournal of fungi (Basel, Switzerland) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fen YangEnzyme and Protein Chemistry, Department of Systems Biology, Technical University of Denmark Lyngby, Denmark ; Department of Plant and Environmental Sciences, Faculty of Science, University of Copenhagen Frederiksberg C, Denmark.
Susanne Jacobsen
Hans J L Jørgensen
David B Collinge
Birte Svensson
Christine Finnie

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ascomycete fungal pathogen Fusarium graminearum (teleomorph stage: Gibberella zeae) is the causal agent of Fusarium head blight in wheat and barley. This disease leads to significant losses of crop yield, and especially quality through the contamination by diverse fungal mycotoxins, which constitute a significant threat to the health of humans and animals. In recent years, high-throughput proteomics, aiming at identifying a broad spectrum of proteins with a potential role in the pathogenicity and host resistance, has become a very useful tool in plant-fungus interaction research. In this review, we describe the progress in proteomics applications toward a better understanding of F. graminearum pathogenesis, virulence, and host defense mechanisms. The contribution of proteomics to the development of crop protection strategies against this pathogen is also discussed briefly.

Indexed as

Fusarium graminearumFusarium head blightpathogenicityplant defense responseproteomics

Identifiers

PMID23450732
PMCPMC3584246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.